CureVac Appoints Antony Blanc as Chief Business Officer and Chief Commercial Officer
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / December 4, 2020 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company...
Staff
Jaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter into Fifth Amendment to the Accounts Receivable Purchase Agreement with Oasis Capital, LLC, Dated May 12, 2020
The Sixth Tranche Accounts Receivable has a gross value of $3,810,587.04, representing customer billings over a 51-day period SAN FRANCISCO,...
Avinger Expands Tigereye(TM) Limited Launch
REDWOOD CITY, CA / ACCESSWIRE / December 4, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the...
Sparta Appoints Mr. Leonard Shara, P.Eng. to Technical Advisory Board
TORONTO, ON / ACCESSWIRE / December 4, 2020 / Sparta Group (TSXV:SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta Capital"...
Philips boosts digital pathology with enhanced informatics to advance precision diagnosis in oncology
Care team reviewing histopathology slides Pathologist reviewing histopathology slides Pathologist reviewing histopathology slides on 2 screens December 4, 2020 Latest...
Brain Scientific to Showcase Disposable EEG Headset NeuroCap™ at American Epilepsy Society Annual Meeting
NEW YORK, Dec. 04, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device...
Y-mAbs and Takeda Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) and Omburtamab in Israel
NEW YORK and PETACH TIKVA, Israel, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB) (the “Company” or...
Ziopharm Details Actions in Response to Shareholder Feedback
Has Held Several Discussions with WaterMill to Reach an Amicable Resolution to Consent Solicitation Board Accepts Resignation of Director Elan...
Centers for Medicare & Medicaid Services Creates New Codes That Establish Specific Payment for Intravascular Lithotripsy Performed Below the Knee
Four New C-Codes for IVL Performed Below the Knee in Hospital Outpatient SettingSANTA CLARA, Calif., Dec. 04, 2020 (GLOBE NEWSWIRE)...
Preston Parsons Announces Investment in Assure Holdings and Files Related Early Warning Report
DENVER, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH) announces that...
Vaccine Genome Researchers Report 99.7% Colinear Identity Between a U.S. Civil War Era Smallpox Vaccine and Horsepox Virus
Findings Published in the Current Issue of the Journal Genome Biology Horsepox is the Vector for Tonix’s Experimental TNX-1800 COVID-19...
Foghorn Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
– Well positioned to advance broad pipeline with recent completion of IPO and Merck collaboration – On track to submit...
Morphic Therapeutic Announces Appointment of Dr. Martin W. Edwards as Member of its Board of Directors
WALTHAM, Mass., Dec. 04, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing oral integrin therapies, today...
Cerevel Therapeutics to Host Investor Webcast Moderated by Stifel
CAMBRIDGE, Mass., Dec. 04, 2020 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of...
Novo Nordisk files for US FDA regulatory approval of once-weekly semaglutide 2.4 mg for weight management
Bagsværd, Denmark, 4 December 2020 – Novo Nordisk today announced the submission of a new drug application (NDA) to the...
Blueberries Medical Announces Closing of the Acquisition of BBV Labs – A Milestone in its Argentina Project
TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Further to its news releases dated March 26, April 4, and July 2,...
HEXO Corp to Release Fiscal First Quarter 2021 Financial Results and Host Investor Webcast
Annual General Meeting Scheduled for December 11, 2020OTTAWA, Dec. 04, 2020 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”)...
Precision BioSciences Reports Positive Interim Results from PBCAR0191 Phase 1/2a Trial in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and R/R B-cell Acute Lymphoblastic Leukemia (B-ALL)
Acceptable Tolerability and Safety Profile in 27 Patients with No Graft versus Host Disease (GvHD), No Grade ≥ 3 Cytokine...
Burning Rock Announces Pricing of Upsized Registered Secondary Public Offering of American Depositary Shares
GUANGZHOU, China, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a...
Aleafia Health Launches High Potency CBD 50 Cannabis Oil
TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is...